1.
Tunisie Medicale [La]. 2008; 86 (8): 768-769
en Francés
| IMEMR
| ID: emr-119691
2.
Tunisie Medicale [La]. 2005; 83 (7): 433-436
en Francés
| IMEMR
| ID: emr-75389
RESUMEN
Plasma cell leukemia is considered as the leukemic variant of multiple myeloma. It is a rare entity. There are two forms: a secondary one following a known myeloma, the diagnosis of which is easy, and a primary one arising without a preceding phase of multiple myeloma. The diagnosis of the latter form is more difficult, a differential diagnosis has often to be discussed with other lymphoproliferative diseases. Prognosis is poor. We report 2 cases of secondary plasma cell leukaemia diagnosed over ten years, among 59 of multiple myeloma cases. We describe the epidemiologic, clinical, biological and evolutionary characteristics